Loading
AL
Acrux Limited Stock: price and insider trades · Australia
2 insiders bought shares over the last 90 days, the latest by Unknown, filed 13 Sept 2026.
Acrux Limited: what insiders have been doing
Acrux Limited is a listed company. Filings by its managers are published through ASX. Between 18 October 2025 and 18 October 2026, 2 insiders published 5 filings.
Only purchases show up on the open market, 5 purchases in all, filed by 2 insiders. The totals exclude 5 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 2 senior executives.
The last purchase on record was published on 13 September 2026, which is 34 days ago.
Across the 2,222 companies tracked on its exchange, the median is 3 filings; at 5 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 5 purchases against no sales.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleUnknown3 buys
Ross Dobinson2 buys
Since the insiders bought
- -18.2%Entry A$0.01 · Close at T+30 A$0.01
- Unknown-8.3%Entry A$0.01 · Close at T+90 A$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 18,407 of 24,166 companies
33.7
score / 100
Value37
Quality31
FCF yld14%
Earn yld-8.2%
EV/EBITDA39.3x
ROE-49%
Gross mgn100%
Net mgn-14%
Debt/EBITDA10.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$4.3M
Gross profitA$4.3M100% margin
EBITDAA$251k6% margin
Net income-A$604k-9.2% margin
Valuation
P/Book4.0x
Beta1.02
Balance sheet & cash
Market capA$7.3M
Total debtA$2.5M
Free Cash FlowA$1M
Debt / Equity172%
Profitability & ownership
ROE-48.5%
ROA-1.9%
% insiders23.2%
% institutions7.0%
Last declaration on 13 September 2026
Declarations5 total
1,128,565 sharesShareASXISIN AU000000ACR3ASX:2924-03113843-3A697574
Canonical exit: 22 Oct 2026 (T+90)
4,925,678 sharesShareASXISIN AU000000ACR3ASX:2924-03096174-3A694527
Canonical exit: 31 Aug 2026 (T+90)
5 of 5 declarations
About Acrux Limited
Acrux Limited is a company listed on the XASX market, specializing in the development of pharmaceutical products. It focuses on innovative solutions to improve patient health.
